• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌少症与轻度迟发性肌肉疾病之间的界限。

Borderlines between Sarcopenia and Mild Late-Onset Muscle Disease.

机构信息

Department of Neurology, Neuromuscular Research Center, Tampere University Hospital, University of Tampere , Tampere , Finland.

Department of Neurology, Neuromuscular Research Center, Tampere University Hospital, University of Tampere , Tampere , Finland ; Department of Medical Genetics, Folkhälsan Institute of Genetics, University of Helsinki , Helsinki , Finland ; Department of Neurology, Vaasa Central Hospital , Vaasa , Finland.

出版信息

Front Aging Neurosci. 2014 Sep 29;6:267. doi: 10.3389/fnagi.2014.00267. eCollection 2014.

DOI:10.3389/fnagi.2014.00267
PMID:25324776
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4179539/
Abstract

Numerous natural or disease-related alterations occur in different tissues of the body with advancing age. Sarcopenia is defined as age-related decrease of muscle mass and strength beginning in mid-adulthood and accelerating in people older than 60 years. Pathophysiology of sarcopenia involves both neural and muscle dependent mechanisms and is enhanced by multiple factors. Aged muscles show loss in fiber number, fiber atrophy, and gradual increase in the number of ragged red fibers and cytochrome c oxidase-negative fibers. Generalized loss of muscle tissue and increased amount of intramuscular fat are seen on muscle imaging. However, the degree of these changes varies greatly between individuals, and the distinction between normal age-related weakening of muscle strength and clinically significant muscle disease is not always obvious. Because some of the genetic myopathies can present at a very old age and be mild in severity, the correct diagnosis is easily missed. We highlight this difficult borderline zone between sarcopenia and muscle disease by two examples: LGMD1D and myotonic dystrophy type 2. Muscle magnetic resonance imaging (MRI) is a useful tool to help differentiate myopathies from sarcopenia and to reach the correct diagnosis also in the elderly.

摘要

随着年龄的增长,身体的不同组织会发生许多自然或与疾病相关的改变。肌肉减少症定义为中年后开始出现并加速的与年龄相关的肌肉质量和力量下降。肌肉减少症的病理生理学涉及神经和肌肉依赖性机制,并受多种因素增强。老年肌肉表现为纤维数量减少、纤维萎缩,以及杂乱红纤维和细胞色素 c 氧化酶阴性纤维数量逐渐增加。肌肉影像学可见肌肉组织普遍丢失和肌肉内脂肪量增加。然而,这些变化的程度在个体之间差异很大,并且正常的与年龄相关的肌肉力量减弱与临床上显著的肌肉疾病之间的区别并不总是很明显。由于一些遗传性肌病可能在非常高龄时出现且程度较轻,因此正确的诊断很容易被忽视。我们通过两个例子强调了肌肉减少症和肌肉疾病之间的这个困难的边界区域:LGMD1D 和肌强直性营养不良 2 型。肌肉磁共振成像(MRI)是一种有用的工具,可以帮助区分肌肉疾病和肌肉减少症,并在老年人中做出正确的诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36fd/4179539/81ed8479edc2/fnagi-06-00267-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36fd/4179539/81ed8479edc2/fnagi-06-00267-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36fd/4179539/81ed8479edc2/fnagi-06-00267-g001.jpg

相似文献

1
Borderlines between Sarcopenia and Mild Late-Onset Muscle Disease.肌少症与轻度迟发性肌肉疾病之间的界限。
Front Aging Neurosci. 2014 Sep 29;6:267. doi: 10.3389/fnagi.2014.00267. eCollection 2014.
2
Late-onset primary muscle diseases mimicking sarcopenia.迟发性原发性肌肉疾病模仿少肌症。
Geriatr Gerontol Int. 2024 Nov;24(11):1099-1110. doi: 10.1111/ggi.15000. Epub 2024 Oct 14.
3
Late-onset neuromuscular disorders in the differential diagnosis of sarcopenia.少肌症鉴别诊断中的迟发性神经肌肉疾病
BMC Neurol. 2021 Jun 25;21(1):241. doi: 10.1186/s12883-021-02264-y.
4
Age-Related Changes in Skeletal Muscle of Cattle.牛骨骼肌的年龄相关变化
Vet Pathol. 2016 Mar;53(2):436-46. doi: 10.1177/0300985815624495. Epub 2016 Feb 11.
5
[Sarcopenia - 2021: Pathophysiology, diagnosis, therapy].[肌肉减少症 - 2021:病理生理学、诊断、治疗]
Orv Hetil. 2021 Jan 3;162(1):3-12. doi: 10.1556/650.2021.32015.
6
Muscle fiber type specific alterations of mitochondrial respiratory function and morphology in aged female mice.衰老雌性小鼠肌肉纤维类型特异性线粒体呼吸功能和形态的改变。
Biochem Biophys Res Commun. 2021 Feb 12;540:116-122. doi: 10.1016/j.bbrc.2020.11.071. Epub 2021 Jan 17.
7
Identification of morphological markers of sarcopenia at early stage of aging in skeletal muscle of mice.小鼠骨骼肌衰老早期肌肉减少症形态学标志物的鉴定
Exp Gerontol. 2016 Oct;83:22-30. doi: 10.1016/j.exger.2016.07.007. Epub 2016 Jul 18.
8
Skeletal muscle lipid content and oxidative activity in relation to muscle fiber type in aging and metabolic syndrome.骨骼肌脂质含量和氧化活性与衰老和代谢综合征中肌肉纤维类型的关系。
J Gerontol A Biol Sci Med Sci. 2015 May;70(5):566-76. doi: 10.1093/gerona/glu086. Epub 2014 Jun 17.
9
Muscle Quality is More Impaired in Sarcopenic Patients With Chronic Obstructive Pulmonary Disease.肌肉质量在患有慢性阻塞性肺疾病的肌少症患者中受损更严重。
J Am Med Dir Assoc. 2016 May 1;17(5):415-20. doi: 10.1016/j.jamda.2015.12.094. Epub 2016 Feb 2.
10
Examining the association between muscle mass, muscle function, and fat indexes in an elderly population.探讨老年人群体中肌肉质量、肌肉功能和脂肪指数之间的关联。
Nutrition. 2021 Mar;83:111071. doi: 10.1016/j.nut.2020.111071. Epub 2020 Nov 19.

引用本文的文献

1
Modeling Musculoskeletal Disorders in Zebrafish: Advancements in Muscle and Bone Research.斑马鱼骨骼肌肉疾病建模:肌肉与骨骼研究进展
Cells. 2024 Dec 30;14(1):28. doi: 10.3390/cells14010028.
2
Palmitic Acid Inhibits Myogenic Activity and Expression of Myosin Heavy Chain MHC IIb in Muscle Cells through Phosphorylation-Dependent MyoD Inactivation.软脂酸通过磷酸化依赖的肌节蛋白 MyoD 失活抑制肌肉细胞的成肌活性和肌球蛋白重链 MHC IIb 的表达。
Int J Mol Sci. 2023 Mar 19;24(6):5847. doi: 10.3390/ijms24065847.
3
Biomechanical Analysis Suggests Myosuit Reduces Knee Extensor Demand during Level and Incline Gait.

本文引用的文献

1
Genetic basis of limb-girdle muscular dystrophies: the 2014 update.肢带型肌营养不良症的遗传基础:2014年更新版
Acta Myol. 2014 May;33(1):1-12.
2
Skeletal muscle function deficit: a new terminology to embrace the evolving concepts of sarcopenia and age-related muscle dysfunction.骨骼肌功能障碍:一个新的术语,包含了进行性的肌少症和与年龄相关的肌肉功能障碍概念。
J Gerontol A Biol Sci Med Sci. 2014 May;69(5):591-4. doi: 10.1093/gerona/glt208.
3
'Pathognomonic' muscle imaging findings in DNAJB6 mutated LGMD1D.DNAJB6 突变型 LGMD1D 的特征性肌肉影像学表现。
生物力学分析表明,Myosuit 在水平和倾斜步态中减少了膝关节伸肌的需求。
Sensors (Basel). 2022 Aug 16;22(16):6127. doi: 10.3390/s22166127.
4
South Asian Working Action Group on SARCOpenia (SWAG-SARCO) - A consensus document.南亚肌肉减少症开放工作组(SWAG-SARCO)——一份共识文件。
Osteoporos Sarcopenia. 2022 Jun;8(2):35-57. doi: 10.1016/j.afos.2022.04.001. Epub 2022 May 25.
5
Cellular Senescence and Aging in Myotonic Dystrophy.肌肉萎缩性侧索硬化症中的细胞衰老和老化。
Int J Mol Sci. 2022 Feb 20;23(4):2339. doi: 10.3390/ijms23042339.
6
Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials.肌强直性营养不良 1 型(DM1)的肌肉磁共振成像:细化肌肉受累情况及其对临床试验的影响。
Eur J Neurol. 2022 Mar;29(3):843-854. doi: 10.1111/ene.15174. Epub 2021 Dec 6.
7
Ryanodine receptor 1-related disorders: an historical perspective and proposal for a unified nomenclature.兰尼碱受体 1 相关疾病:历史视角与统一命名建议。
Skelet Muscle. 2020 Nov 16;10(1):32. doi: 10.1186/s13395-020-00243-4.
8
A novel COL6A2 mutation causing late-onset limb-girdle muscular dystrophy.一个新的 COL6A2 突变导致的迟发性肢带型肌营养不良症。
J Neurol. 2019 Jul;266(7):1649-1654. doi: 10.1007/s00415-019-09307-y. Epub 2019 Apr 8.
9
The Bottom-Up Rise Strength Transfer in Elderly After Endurance and Resistance Training: The BURST.耐力和阻力训练后老年人自下而上的力量转移:BURST研究
Front Physiol. 2019 Jan 14;9:1944. doi: 10.3389/fphys.2018.01944. eCollection 2018.
10
Editorial: Pathophysiological Mechanisms of Sarcopenia in Aging and in Muscular Dystrophy: A Translational Approach.社论:衰老和肌肉萎缩症中肌肉减少症的病理生理机制:一种转化医学方法。
Front Aging Neurosci. 2015 Aug 13;7:153. doi: 10.3389/fnagi.2015.00153. eCollection 2015.
Eur J Neurol. 2013 Dec;20(12):1553-9. doi: 10.1111/ene.12239. Epub 2013 Jul 19.
4
Prevalence of sarcopenia in community-dwelling older people in the UK using the European Working Group on Sarcopenia in Older People (EWGSOP) definition: findings from the Hertfordshire Cohort Study (HCS).使用欧洲老年人肌少症工作组(EWGSOP)定义评估英国社区居住老年人肌少症的流行率:赫特福德郡队列研究(HCS)的结果。
Age Ageing. 2013 May;42(3):378-84. doi: 10.1093/ageing/afs197. Epub 2013 Feb 5.
5
The myotonic dystrophies: molecular, clinical, and therapeutic challenges.肌强直性营养不良症:分子、临床和治疗挑战。
Lancet Neurol. 2012 Oct;11(10):891-905. doi: 10.1016/S1474-4422(12)70204-1.
6
Sarcopenia in the elderly: basic and clinical issues.老年人肌肉减少症:基础与临床问题。
Geriatr Gerontol Int. 2012 Jul;12(3):388-96. doi: 10.1111/j.1447-0594.2012.00851.x. Epub 2012 Apr 25.
7
Eight new mutations and the expanding phenotype variability in muscular dystrophy caused by ANO5.ANO5 所致肌营养不良症的 8 种新突变及扩展的表型变异性。
Neurology. 2012 Mar 20;78(12):897-903. doi: 10.1212/WNL.0b013e31824c4682. Epub 2012 Mar 7.
8
Mutations affecting the cytoplasmic functions of the co-chaperone DNAJB6 cause limb-girdle muscular dystrophy.影响共伴侣蛋白 DNAJB6 细胞质功能的突变会导致肢带型肌营养不良症。
Nat Genet. 2012 Feb 26;44(4):450-5, S1-2. doi: 10.1038/ng.1103.
9
Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland.人群中肌强直性营养不良的发病率:芬兰 2 型肌强直性营养不良(DM2)突变的发病率高于预期。
Eur J Hum Genet. 2011 Jul;19(7):776-82. doi: 10.1038/ejhg.2011.23. Epub 2011 Mar 2.
10
The enigma of 7q36 linked autosomal dominant limb girdle muscular dystrophy.7q36 连锁显性遗传肢带型肌营养不良症之谜。
J Neurol Neurosurg Psychiatry. 2010 Aug;81(8):834-9. doi: 10.1136/jnnp.2009.192351.